Euroopa farmakopöa asjus

Signe Leito Saatja: [email protected] Saatmisaeg: neljapäev, 9. aprill 2026 18:31 Adressaat: Signe Leito Teema: Hyoscyamine sulfate (501): manufacturer contacts or suppression from the European Pharmacopoeia (Ph. Eur.): EDQM-2026-01792-mail Järeltegevuse lipp: Järeltegevus Olekulipp: Lipuga märgitud Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2026-01792-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out on monograph Hyoscyamine sulfate (501) to gather information on potential manufacturers and, in absence of the later, to propose launching a procedure to suppress the monograph from the Ph. Eur. In order to have access to the survey, please copy and paste the following link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=235437&newtest=Y&lang=en Deadline for replies: 3 May 2026 Thank you. Best regards, On behalf of Mrs Aurelie Barth Andreea Mocoi Administrative Support Assistant European Pharmacopoeia Department European Directorate for the Quality of Medicines & HealthCare Council of Europe - Conseil de l'Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store Stay connected with the EDQM To reach us, we invite you to contact us electronically. You can also contact us via HelpDesk https://www.edqm.eu / https://store.edqm.eu Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2026-01792-mail 1